AEON Biopharma, Inc.

Market Cap

$19M

Healthcare·Biotechnology·🇺🇸 United States·AMEX

Healthcare·Biotechnology·🇺🇸·AMEX

Stock Price

$0.30-$0.81 (-73.00%)

Jul 15, 2026

52W High $1.4052W Low $0.30

Company Details

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatmen...

Leadership

Robert Bancroft

President, CEO & Director

Alex Wilson

Chief Legal & Strategy Officer and Corporate Secretary

Chad K. Oh M.D.

Chief Medical Officer

John A. Bencich M.B.A.

Chief Financial Officer

Jennifer Sy

Chief Accounting Officer

IPO Date

Apr 12, 2021

Website

www.aeonbiopharma.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$60M

EPS (Diluted)

Free Cash Flow

-$12M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee